Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (127)
- Compliance and enforcement (33)
- Import and export (31)
- Shortages and supply disruptions (16)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
786 result(s) found, displaying 701 to 725
-
Market actionsWe are recalling all batches of Savacol Antiseptic Mouth & Throat Rinse (alcohol-free) due to bacterial contamination.
-
-
Market actionsXigris (drotrecogin alfa) is being withdrawn from the market because it does not improve survival rates in severe sepsis patients. Stop using it and consult your doctor for alternative treatments.
-
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Market actionsAbout Octagam 5%: lifting of the voluntary recall
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
-
-
Safety alerts
-
Safety alertsWe are advising that Movectro (cladribine) has been withdrawn from supply in Australia due to commercial reasons.
-
Safety alerts
-
Safety alerts
-
Safety alertsWe are reviewing the safety of the Pneumovax 23 vaccine due to reports of severe local reactions and have updated our revaccination recommendations.
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsOn 26 January 2011, the US Food and Drug Administration (FDA) announced a safety communication to warn about an association between breast implants and anaplastic large cell lymphoma. The risk of a patient developing this type of lymphoma is very low.